Literature DB >> 11732932

Left ventricular changes in isolated office hypertension: a blood pressure-matched comparison with normotension and sustained hypertension.

A M Grandi1, R Broggi, S Colombo, R Santillo, D Imperiale, A Bertolini, L Guasti, A Venco.   

Abstract

BACKGROUND: Isolated office (IO) hypertension is a benign condition according to some researchers, whereas others believe it is associated with cardiovascular abnormalities and increased cardiovascular risk. The aim of this study is to compare morphofunctional characteristics of the left ventricle (LV) in IO hypertensive subjects, normotensive subjects (hereafter, hypertensives and normotensives), and never-treated sustained hypertensives. The 3 groups were matched not only by age, sex, and body mass index but also by clinic blood pressure (BP) (IO hypertensives and sustained hypertensives) and daytime BP (IO hypertensives and normotensives).
METHODS: We enrolled 42 IO hypertensives (clinic BP > 140 and/or 90 mm Hg and daytime BP < or = 130/80 mm Hg), 42 sustained hypertensives (clinic BP > 140 and/or 90 mm Hg and daytime BP > or = 140 and/or 90 mm Hg) and 42 normotensives (clinic BP < 135 and/or 85 mm Hg and daytime BP < or = 130/80 mm Hg). Left ventricular morphologic features and function were assessed using digitized M-mode echocardiography.
RESULTS: Compared with normotensives, IO hypertensives had significantly thicker LV walls, increased LV mass, reduced diastolic function, increased prevalence of LV hypertrophy, and preclinical diastolic dysfunction. Sustained hypertensives, compared with IO hypertensives, had significantly thicker LV wall, higher LV mass, and lower diastolic function, whereas the prevalence of LV hypertrophy and preclinical diastolic dysfunction was greater than in IO hypertensives, but the difference did not reach statistical significance (P = .29).
CONCLUSIONS: Comparing matched BP groups, IO hypertensives have LV morphofunctional characteristics considerably different from normotensives and qualitatively similar to sustained hypertensives. Therefore, our results support the hypothesis that IO hypertension should not be considered as simply a benign condition.

Entities:  

Mesh:

Year:  2001        PMID: 11732932     DOI: 10.1001/archinte.161.22.2677

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Clinical trials report. White-coat hypertension and stroke incidence.

Authors:  Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

2.  Left ventricular mass index in children with white coat hypertension.

Authors:  Marc B Lande; Cecilia C Meagher; Susan Gross Fisher; Puneet Belani; Hongyue Wang; Megan Rashid
Journal:  J Pediatr       Date:  2008-03-19       Impact factor: 4.406

Review 3.  Hypertension management: differing points of view: ambulatory blood pressure monitoring for every hypertensive patient: it's about time!: the argument for.

Authors:  Lawrence R Krakoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-12       Impact factor: 3.738

4.  Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

Authors:  Richard E Katholi; Daniel M Couri
Journal:  Int J Hypertens       Date:  2011-06-30       Impact factor: 2.420

5.  A Polymorphism within the Promoter of the Dopamine Receptor D1 (DRD1 -48A/G) Associates with Impaired Kidney Function in White Hypertensive Patients.

Authors:  Ersilia Cipolletta; Michele Ciccarelli; Raffaele Izzo; Rosa Finelli; Bruno Trimarco; Guido Iaccarino
Journal:  Transl Med UniSa       Date:  2012-01-18

6.  The Impact of White-Coat Hypertension on Cardiac Mechanics.

Authors:  Marijana Tadic; Cesare Cuspidi; Branislava Ivanovic; Vladan Vukomanovic; Marina Djelic; Vera Celic; Vesna Kocijancic
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-21       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.